Tg Therapeutics reported $94K in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US USD 14.81B 229M
Amgen AMGN:US USD 6.65B 58M
Ardelyx ARDX:US USD 4.99M 2.46M
Arrowhead Research ARWR:US USD 32.41M 119.39M
Bayer BAYN:GR EUR 11.28B 1.54B
Biogen BIIB:US USD 2.51B 80.6M
Corcept Therapeutics CORT:US USD 101.73M 1.66M
Curis CRIS:US USD 2.82M 432K
Dynavax Technologies DVAX:US USD 167.74M 88.73M
Gilead Sciences GILD:US USD 7.04B 782M
Infinity Pharmaceuticals INFI:US USD 712K 26K
Intercept Pharmaceuticals ICPT:US USD 77.59M 5.83M
Johnson & Johnson JNJ:US USD 23.79B 229M
Karyopharm Therapeutics KPTI:US USD 36.14M 3.53M
Novartis NOVN:VX USD 12.84B 243M
Novavax NVAX:US USD 734.58M 548.65M
Ptc Therapeutics PTCT:US USD 217.13M 51.6M
Puma Biotechnology PBYI:US USD 57.1M 2.42M
Regeneron Pharmaceuticals REGN:US USD 2.94B 79M
Roche Holding ROG:VX CHF 14.74B 1.7B
Tg Therapeutics TGTX:US USD 94K 500K
Vertex Pharmaceuticals VRTX:US USD 2.33B 138.1M